Skip to main content
. 2022 Feb 25;2022:5099312. doi: 10.1155/2022/5099312

Figure 1.

Figure 1

New anti-TB drugs in clinical trials (a), the chemical structures of vasicoline, vasicolinone, vasicinone, vasicine, adhatodine, and anisotine (b), the chemical structures of BTZ-043, PBTZ-169, OPC-167832, and TBA-7371 (c), and the chemical structure of CPZEN-45 (d).